BR9809022A - anti-inflammatory topical nasal compositions - Google Patents

anti-inflammatory topical nasal compositions

Info

Publication number
BR9809022A
BR9809022A BR9809022-4A BR9809022A BR9809022A BR 9809022 A BR9809022 A BR 9809022A BR 9809022 A BR9809022 A BR 9809022A BR 9809022 A BR9809022 A BR 9809022A
Authority
BR
Brazil
Prior art keywords
nasal
agent
compositions
anti
gt
Prior art date
Application number
BR9809022-4A
Other languages
Portuguese (pt)
Inventor
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US4430697P priority Critical
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to PCT/US1998/006483 priority patent/WO1998048839A1/en
Publication of BR9809022A publication Critical patent/BR9809022A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Abstract

Patente de Invenção: <B>"COMPOSIçõES ANTIINFLAMATóRIAS NASAIS TóPICAS"<D>. Patent of Invention: <B> "nasal topical antiinflammatory compositions" <D>. A presente invenção proporciona composições nasais topicamente aplicáveis compreendendo uma quantidade terapeuticamente eficaz de um agente antiinflamatório e uma quantidade terapeuticamente eficaz de pelo menos um agente selecionado do grupo consistindo de um vasoconstritor,um inibidor neuramidinase um inibidor leucotrieno, um anti-histamínico, um agente antialérgico, um agente anticolinérgico, um anestésico e um agente mucolítico. The present invention provides topically applicable nasal compositions comprising a therapeutically effective amount of an antiinflammatory agent and a therapeutically effective amount of at least one selected from the group agent consisting of a vasoconstrictor, an inhibitor neuraminidase a leukotriene inhibitor, an antihistamine, an antiallergic agent , an anticholinergic agent, an anesthetic and a mucolytic agent. As presentes composições são úteis como sprays nasais e gotas nasais para o tratamento de condições nasais e de sinus. The present compositions are useful as nasal drops and nasal sprays for treatment of nasal and sinus conditions.
BR9809022-4A 1997-04-30 1998-04-02 anti-inflammatory topical nasal compositions BR9809022A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US4430697P true 1997-04-30 1997-04-30
PCT/US1998/006483 WO1998048839A1 (en) 1997-04-30 1998-04-02 Topical nasal antiinflammatory compositions

Publications (1)

Publication Number Publication Date
BR9809022A true BR9809022A (en) 2000-08-01

Family

ID=21931638

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809022-4A BR9809022A (en) 1997-04-30 1998-04-02 anti-inflammatory topical nasal compositions

Country Status (8)

Country Link
EP (1) EP0979105A1 (en)
JP (1) JP2001524108A (en)
CN (1) CN1253508A (en)
AU (1) AU6878098A (en)
BR (1) BR9809022A (en)
CA (1) CA2281789A1 (en)
IL (1) IL131492D0 (en)
WO (1) WO1998048839A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0998272T3 (en) * 1997-08-26 2003-08-25 Aventis Pharma Inc A pharmaceutical composition for the combination piperidinoalkanoldekongestivum
DK1041990T3 (en) * 1997-12-23 2006-10-02 Schering Corp Composition for the treatment of respiratory diseases and skin diseases having at least one leukotriene antagonist and at least one antihistamine
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
IT1313567B1 (en) * 1999-07-27 2002-09-09 Zambon Spa Use of n-acetyl-cysteine ​​for the preparation of topical composizionifarmaceutiche for the treatment of allergic diseases of the
DE10007203A1 (en) 2000-02-17 2001-08-23 Asta Medica Ag Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist
CA2460140C (en) 2001-09-18 2009-09-01 Nycomed Danmark Aps Compositions for treatment of common cold
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2005533076A (en) * 2002-06-20 2005-11-04 ノバルテイス・コンシユーマー・ヘルス・エス・アー Nasal compositions comprising a mucopolysaccharide and propylene glycol
AU2003273396B2 (en) 2002-08-30 2008-12-11 Covis Pharma B.V. The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
ES2471139T3 (en) * 2003-08-06 2014-06-25 Galephar M/F advantageous combinations for inhalation of nacistelina and bronchodilators
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
RS58377B1 (en) 2004-11-24 2019-04-30 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods of use thereof
AU2006224842B2 (en) 2005-03-16 2011-09-29 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
US8093301B2 (en) * 2005-08-26 2012-01-10 Meiji Co., Ltd. Anti-allergic agent
CA2657581A1 (en) * 2006-07-11 2008-01-17 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
JP2008143845A (en) * 2006-12-11 2008-06-26 Daiichi Sankyo Healthcare Co Ltd Nasal drop composition and nasal drop spraying tool
BR112014029442A2 (en) * 2012-05-25 2017-06-27 Xlear Inc antimucosas xylitol-based compositions and related methods and compositions
CN104667256B (en) * 2015-03-18 2017-05-03 江苏威克斯医疗科技有限公司 One kind of nasal mucociliary care and use the rinse liquid
CN107753485A (en) * 2017-11-28 2018-03-06 赵永宏 Medicinal composition with nasal decongestant and anesthetic effects, and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4552899B1 (en) * 1984-04-09 1992-10-20 Analgesic Associates
JPH0753671B2 (en) * 1985-12-26 1995-06-07 積水化学工業株式会社 Transdermal, transmucosal formulation
DE69229880D1 (en) * 1991-11-19 1999-09-30 Univ Virginia Combined antiviral anti-mediator treatment (COVAM) from ordinary colds
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
AU6392496A (en) * 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
WO1997001341A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
DE19532714A1 (en) * 1995-09-05 1997-03-06 Bayer Ag Combination of 5-lipoxygenase and leukotriene synthesis inhibitors with glucocorticosteroids
EP0780127A1 (en) * 1995-12-19 1997-06-25 THE PROCTER &amp; GAMBLE COMPANY A nasal spray containing a steroid and a antihistamine

Also Published As

Publication number Publication date
CN1253508A (en) 2000-05-17
JP2001524108A (en) 2001-11-27
CA2281789A1 (en) 1998-11-05
IL131492D0 (en) 2001-01-28
AU6878098A (en) 1998-11-24
WO1998048839A1 (en) 1998-11-05
EP0979105A1 (en) 2000-02-16

Similar Documents

Publication Publication Date Title
RU2196769C2 (en) Derivatives of aminobenzoic acid, pharmaceutical composition
ES2092460T3 (en) Nitric donor composition for treating anal disorders oxide.
EA199900137A1 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
BR9911071A (en) Preparations for the application of anti-inflammatory agents, especially antiseptic and / or promoters of wound healing in the upper respiratory tract and / or ear
DOP2006000252A (en) Mutual prodrugs of glucosamine and glucosamine / anti-inflammatory compositions and methods
DZ3468A1 (en) 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyle) oxy! -11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4, -diene-17 carbothioic acid s-fluoromethyl ester used as anti-inflammatory agent
EA200100524A1 (en) Anthranilic acid amides and their use as medicaments
MA26901A1 (en) Novel pharmaceutical composition
GT199700094A (en) Arylsulfonylamino hydroxamic acid derivatives.
EA200301216A1 (en) Substituted multicyclic heteroaryls quinuclidine for the treatment of diseases
BR0115109A (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
HN1999000045A (en) Bicyclic hydroxamic acid derivatives
NO20005767D0 (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
BR9917080A (en) The compound, pharmaceutical composition, use of the compound and method of treatment or prevention of a thromboembolic disorder
NO20002217L (en) Cyclopentane heptanoic acid, 2-heteroarylalkenylderivater as therapeutic agents
BR0200782A (en) Compounds for treating ischemia
ECSP034896A (en) Aromatic dicarboxylic acid derivatives
ES2107648T3 (en) Arylsulfonamido substituted hydroxamic acids.
BR9709959A (en) tricyclic derivatives of phenylamino substituted for the treatment of hyperproliferative diseases
BR9911305A (en) Nitrate salts, process for preparing the same, pharmaceutical compositions, and use thereof
EA200602191A1 (en) 5,5-disubstituted-2-amino-4-thiazolidinones and their method of preparation, a pharmaceutical composition and method of treatment
BR9904998A (en) hydroxyamide derivatives of 5-oxo-pyrrolidine-2-carboxylic acid
BR0310106A (en) A compound, a process for producing a compound, pharmaceutical composition, method and use of the compound for treating a subject suffering from a condition or disease patalógica
SE9504661D0 (en) New compounds
SE0102616D0 (en) Novel compounds

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/57 (2006.01), A61K 31/58 (2006.0